Electricite de France SA
F:E2F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Electricite de France SA
F:E2F
|
FR |
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
A
|
Alpha Services and Holdings SA
ATHEX:ALPHA
|
GR |
|
Becton Dickinson and Co
NYSE:BDX
|
US |
|
B
|
Beryl 8 Plus PCL
SET:BE8
|
TH |
|
K
|
Kering SA
DUS:PPX
|
FR |
|
O
|
O'Reilly Automotive Inc
F:OM6
|
US |
|
Fox Corp
F:FO5
|
US |
|
C
|
Commerzbank AG
SWB:CBK
|
DE |
|
R
|
Reckitt Benckiser Group PLC
XMUN:3RB
|
UK |
|
C
|
Commerzbank AG
XMUN:CBK
|
DE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is E2F's stock price target?
Not Available
E2F does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Electricite de France SA?
Projected CAGR
-17%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is -17%.